tiprankstipranks
Tenax Therapeutics (TENX)
NASDAQ:TENX
US Market
TENX
Tenax Therapeutics
RESEARCH TOOLSreports
Want to see TENX full AI Analyst Report?

Tenax Therapeutics (TENX) Income Statement

648 Followers

Tenax Therapeutics Income Statement

Last quarter (Q4 2025), Tenax Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Tenax Therapeutics's net income was $-15.54M. See Tenax Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Mar 23Mar 22
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 56.38M$ 19.49M$ 8.23M$ 11.05M$ 32.73M
Depreciation and Amortization
$ 0.00$ 0.00$ 8.00K$ 113.33K$ 108.98K
EBITDA
$ -56.38M$ -17.58M$ -7.68M$ -10.93M$ -32.36M
Operating Income
$ -56.38M$ -19.49M$ -8.23M$ -11.05M$ -32.73M
Other Income/Expenses
$ 3.79M$ 1.89M$ 523.00K$ 4.75K$ 253.88K
Pretax Income
$ -52.60M$ -17.60M$ -7.71M$ -11.05M$ -32.47M
Net Income
$ -52.60M$ -17.60M$ -7.71M$ -11.05M$ -32.47M
Per Share Metrics
Basic EPS
$ -1.34$ -1.15$ -31.09$ -600.80$ -2.52K
Diluted EPS
$ -1.34$ -1.15$ -31.04$ -600.80$ -2.52K
Weighted Average Shares Outstanding
 39.22M 15.27M 248.00K 18.39K 12.86K
Weighted Average Shares Outstanding (Diluted)
 39.22M 15.27M 248.45K 18.39K 12.86K
Currency in USD

Tenax Therapeutics Earnings and Revenue History